Skip to content

Clinical trial of herbal formulation improving respiratory immunity in children.

A pilot, prospective, interventional study assessing safety and efficacy of HFIMJ in improving respiratory immunity in children. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034779
Enrollment
30
Registered
2021-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Herbal formulation: 10 ml of formulation twice a day for 30 days Control Intervention1: Nil: Nil

Sponsors

Siddhayu Ayurvedic Research Fdn Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy children of either sex of 3-13 years (both inclusive) Ready to provide informed consent from parent/ legally accepted Guardian No significant medical or surgical disease/s at the time of screening No history of allergic conditions at screening by the related ingredients like investigational product Willing to come for the follow up visits for evaluation

Exclusion criteria

Exclusion criteria: Presence of any clinically significant medical or surgical condition requiring long term treatment Subjects participating/participated in another clinical study within 3 months before recruitment Evidence of significant uncontrolled concomitant disease which in the Investigators opinion would preclude patient participation Immunologically compromised children

Design outcomes

Primary

MeasureTime frame
Number of episodes, severity and duration of illness during the study period Complete Hemogram Serum IgG, IgM Levels of CD3,4 and 8 cells Timepoint: On screening day 15 and day 30

Secondary

MeasureTime frame
Digestive behavior questionnaire analysis Assessment of energy and stamina in parent reported questionnaire Drug compliance Tolerability of study drugs Adverse events/ Adverse drug reactions Timepoint: On screening day 15 and day 30

Countries

India

Contacts

Public ContactMr Sharad Dhurde

Siddhayu Ayurvedic Research Fdn Pvt Ltd

bshrikhande@siddhayu.com9371490526

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026